General Information of the Compound
| Compound ID |
CP0401957
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(2-methylpropyl)pyridine-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H37N3O4
|
||||||||||||||||||
| Molecular Weight |
503.643
|
||||||||||||||||||
| Canonical SMILES |
CC(C)Cc1cnccc1C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CC1)c45
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H37N3O4/c1-17(2)13-20-15-31-11-8-21(20)28(35)32-22-7-9-30(36)24-14-19-5-6-23(34)26-25(19)29(30,27(22)37-26)10-12-33(24)16-18-3-4-18/h5-6,8,11,15,17-18,22,24,27,34,36H,3-4,7,9-10,12-14,16H2,1-2H3,(H,32,35)/t22-,24-,27+,29+,30-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UZZSGLAPZOOSMQ-ZHRQHTTBSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01791, Delta-type opioid receptor
Protein ID: PT02264, Kappa-type opioid receptor
Protein ID: PT02699, Mu-type opioid receptor